SCM
Soleus Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.61M | Sell |
3,261,707
-4,523,293
| -58% | -$7.78M | 0.37% | 50 |
|
|
2025
Q1 | $25.9M | Buy |
7,785,000
+1,225,000
| +19% | +$4.08M | 1.87% | 15 |
|
|
2024
Q4 | $48.5M | Sell |
6,560,000
-1,968,500
| -23% | -$14.6M | 3.05% | 7 |
|
|
2024
Q3 | $80.1M | Buy |
8,528,500
+980,500
| +13% | +$9.21M | 6.2% | 1 |
|
|
2024
Q2 | $60.5M | Buy |
7,548,000
+4,043,000
| +115% | +$32.4M | 5.34% | 2 |
|
|
2024
Q1 | $51.9M | Buy |
3,505,000
+2,950,000
| +532% | +$43.7M | 3.86% | 3 |
|
|
2023
Q4 | $4.51M | Sell |
555,000
-684,777
| -55% | -$5.57M | 0.5% | 46 |
|
|
2023
Q3 | $5.64M | Hold |
1,239,777
| – | – | 0.52% | 48 |
|
|
2023
Q2 | $8.73M | Sell |
1,239,777
-210,000
| -14% | -$1.48M | 0.97% | 32 |
|
|
2023
Q1 | $8.86M | Buy |
+1,449,777
| New | +$8.86M | 0.92% | 29 |
|
|
2022
Q4 | – | Sell |
-1,025,200
| Closed | -$9.82M | – | 82 |
|
|
2022
Q3 | $9.82M | Buy |
1,025,200
+305,600
| +42% | +$2.93M | 1.33% | 25 |
|
|
2022
Q2 | $7.94M | Buy |
+719,600
| New | +$7.94M | 1.24% | 28 |
|